SynBioBeta Speaker
Matt Anderson-Baron
Future Fields
CEO
Dr. Matt Anderson-Baron is the cofounder and CEO of Future Fields, an Edmonton-based biomanufacturing company that is redefining the production of recombinant proteins. Matt is the inventor of Future Fields pioneering technology, the EntoEngine™, the world’s first synthetic biology platform to utilize the common fruit fly (Drosophila melanogaster) as a sustainable, scalable alternative to traditional bioreactors.Driven by the mission to "make the unmakeable," Matt has been instrumental in transitioning Future Fields from a bold startup concept into a global biomanufacturing partner. The company now works with industry leaders across life sciences, agrisciences, and drug discovery by manufacturing proteins at scale with a fraction of the environmental footprint and cost associated with conventional methods.Matt is A PhD-trained cell biologist turned entrepreneur, and combines a deep scientific rigor with a passion for disruptive technology. Formerly a touring punk-rock musician before returning to academia, he leverages his unique background to foster a culture of curiosity with candor and innovation.Future Fields is committed to the sustainable biotech, as a Green-certified lab, and as members of 1% for the Planet and the UN Global Compact.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Matt
This Year
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
